Patents by Inventor Pam Golden

Pam Golden has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Solid Dispersion Forms of Rifaximin
    Publication number: 20250082616
    Abstract: Provided herein are solid dispersions comprising rifaximin and pharmaceutical compositions and uses thereof.
    Type: Application
    Filed: November 25, 2024
    Publication date: March 13, 2025
    Inventors: Pam GOLDEN, Mohammed A. KABIR
  • SOLID DISPERSION FORMS OF RIFAXIMIN
    Publication number: 20240100028
    Abstract: Provided herein are solid dispersions comprising rifaximin and pharmaceutical compositions and uses thereof.
    Type: Application
    Filed: April 28, 2023
    Publication date: March 28, 2024
    Inventors: Pam Golden, Mohammed A. Kabir
  • Solid dispersion forms of rifaximin
    Patent number: 11660292
    Abstract: Provided herein are solid dispersions comprising rifaximin and pharmaceutical compositions and uses thereof.
    Type: Grant
    Filed: September 7, 2021
    Date of Patent: May 30, 2023
    Assignee: Salix Pharmaceuticals, Inc.
    Inventors: Pam Golden, Mohammed A. Kabir
  • Solid dispersion forms of rifaximin
    Patent number: 11311521
    Abstract: Provided herein are solid dispersions comprising rifaximin and pharmaceutical compositions and uses thereof.
    Type: Grant
    Filed: September 7, 2021
    Date of Patent: April 26, 2022
    Assignee: Salix Pharmaceuticals, Inc.
    Inventors: Pam Golden, Mohammed A. Kabir
  • SOLID DISPERSION FORMS OF RIFAXIMIN
    Publication number: 20220040157
    Abstract: Provided herein are solid dispersions comprising rifaximin and pharmaceutical compositions and uses thereof.
    Type: Application
    Filed: September 7, 2021
    Publication date: February 10, 2022
    Inventors: Pam Golden, Mohammed A. Kabir
  • SOLID DISPERSION FORMS OF RIFAXIMIN
    Publication number: 20210401813
    Abstract: Provided herein are solid dispersions comprising rifaximin and pharmaceutical compositions and uses thereof.
    Type: Application
    Filed: September 7, 2021
    Publication date: December 30, 2021
    Inventors: Pam Golden, Mohammed A. Kabir
  • Solid dispersion forms of rifaximin
    Patent number: 11129817
    Abstract: Provided herein are solid dispersions comprising rifaximin and pharmaceutical compositions and uses thereof.
    Type: Grant
    Filed: February 12, 2021
    Date of Patent: September 28, 2021
    Assignee: Salix Pharmaceuticals, Inc.
    Inventors: Pam Golden, Mohammed A. Kabir
  • SOLID DISPERSION FORMS OF RIFAXIMIN
    Publication number: 20210205279
    Abstract: Provided herein are solid dispersions comprising rifaximin and pharmaceutical compositions and uses thereof.
    Type: Application
    Filed: February 12, 2021
    Publication date: July 8, 2021
    Inventors: Pam Golden, Mohammed A. Kabir
  • Solid dispersion forms of rifaximin
    Patent number: 10874647
    Abstract: Provided herein are solid dispersions comprising rifaximin and pharmaceutical compositions and uses thereof.
    Type: Grant
    Filed: March 29, 2019
    Date of Patent: December 29, 2020
    Assignee: Salix Pharmaceuticals, Inc.
    Inventors: Pam Golden, Mohammed A. Kabir
  • FORMULATIONS OF RIFAXIMIN AND USES THEREOF
    Publication number: 20200397904
    Abstract: The present invention relates to new rifaximin forms comprising solid dispersions of rifaximin, methods of making same and to their use in medicinal preparations and therapeutic methods.
    Type: Application
    Filed: June 30, 2020
    Publication date: December 24, 2020
    Inventors: Jon Selbo, Jing Teng, Mohammed A. Kabir, Pam Golden
  • METHODS FOR RETREATING IRRITABLE BOWEL SYNDROME (IBS)
    Publication number: 20200276170
    Abstract: The present invention provides new methods and kits for the retreatment of IBS.
    Type: Application
    Filed: April 14, 2020
    Publication date: September 3, 2020
    Inventors: Pam Golden, Enoch Bortey, William Forbes, Craig Paterson
  • METHODS FOR RETREATING IRRITABLE BOWEL SYNDROME (IBS)
    Publication number: 20200230116
    Abstract: The present invention provides new methods and kits for the retreatment of IBS.
    Type: Application
    Filed: January 17, 2020
    Publication date: July 23, 2020
    Inventors: Pam Golden, Enoch Bortey, William Forbes, Craig Paterson
  • Methods for retreating irritable bowel syndrome (IBS)
    Patent number: 10610522
    Abstract: The present invention provides new methods and kits for the retreatment of IBS.
    Type: Grant
    Filed: December 30, 2016
    Date of Patent: April 7, 2020
    Assignee: Salix Pharmaceuticals, Inc.
    Inventors: Pam Golden, Enoch Bortey, William Forbes, Craig Paterson
  • METHODS FOR TREATING INFECTION
    Publication number: 20200069664
    Abstract: The present invention provides new methods and kits for treating and preventing bacterial infection.
    Type: Application
    Filed: September 5, 2019
    Publication date: March 5, 2020
    Inventors: Herbert L. Du Pont, Zhi-Dong Jiang, Eric Brown, Charles Darkoh, Pam Golden
  • IBS microbiota and uses thereof
    Patent number: 10493064
    Abstract: The instant application provides methods of diagnosing and treating a subject having IBS. In certain embodiments, the methods also include diagnosing subjects who will respond to IBS treatment with rifaximin.
    Type: Grant
    Filed: November 3, 2016
    Date of Patent: December 3, 2019
    Assignee: Salix Pharmaceuticals, Inc.
    Inventors: Pam Golden, Anthony Fodor, Enoch Bortey, William Forbes
  • SOLID DISPERSION FORMS OF RIFAXIMIN
    Publication number: 20190224175
    Abstract: Provided herein are solid dispersions comprising rifaximin and pharmaceutical compositions and uses thereof.
    Type: Application
    Filed: March 29, 2019
    Publication date: July 25, 2019
    Inventors: Pam Golden, Mohammed A. Kabir
  • FORMULATIONS OF RIFAXIMIN AND USES THEREOF
    Publication number: 20170333562
    Abstract: The present invention relates to new rifaximin forms comprising solid dispersions of rifaximin, methods of making same and to their use in medicinal preparations and therapeutic methods.
    Type: Application
    Filed: June 6, 2017
    Publication date: November 23, 2017
    Inventors: Jon Selbo, Jing Teng, Mohammed A. Kabir, Pam Golden
  • Formulations of rifaximin and uses thereof
    Patent number: 9737610
    Abstract: The present invention relates to new rifaximin forms comprising solid dispersions of rifaximin, methods of making same and to their use in medicinal preparations and therapeutic methods.
    Type: Grant
    Filed: April 10, 2014
    Date of Patent: August 22, 2017
    Assignee: Salix Pharmaceuticals, Ltd
    Inventors: Jon Selbo, Jing Teng, Mohammed A. Kabir, Pam Golden
  • Rifaximin derivative and uses thereof
    Patent number: 9725466
    Abstract: 25-desacetyl rifaximin or a pharmaceutically acceptable salt thereof is provided. Methods of treatment of bowl related disorders using isolated and/or purified 25-desacetyl rifaximin or a pharmaceutically acceptable salt thereof are also provided.
    Type: Grant
    Filed: May 16, 2016
    Date of Patent: August 8, 2017
    Assignees: Salix Pharmaceuticals, Ltd, Alfa Wassermann S.P.A.
    Inventors: Pam Golden, Mohammed A. Kabir, Giuseppe Claudio Viscomi, Manuela Campana, Donatella Confortini, Miriam Barbanti
  • IBS MICROBIOTA AND USES THEREOF
    Publication number: 20170151220
    Abstract: The instant application provides methods of diagnosing and treating a subject having IBS. In certain embodiments, the methods also include diagnosing subjects who will respond to IBS treatment with rifaximin.
    Type: Application
    Filed: November 3, 2016
    Publication date: June 1, 2017
    Inventors: Pam Golden, Anthony Fodor, Enoch Bortey, William Forbes